LifeMD, Inc. — Director's Dealing 2022

Jan 28, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LifeMD, Inc. (LFMD)
CIK: 0000948320
Period of Report: 2022-01-27

Reporting Person: Benathen Marc David (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-01-27	Common Stock	M	25000	—	Acquired	52554	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-27	Restricted Stock Unit	$0	A	75000	Acquired		Common Stock (75000)	Direct
2022-01-27	Restricted Stock Unit	$	M	25000	Disposed		Common Stock (25000)	Direct

Footnotes

F1: 25,000 RSUs vested on January 27, 2022. Of the remaining RSUs, 25,000 vest on January 27, 2023 and 25,000 vest on January 27, 2024.

F2: Restricted stock units convert into common stock on a one-for-one basis.